4.7 Review

Ventilator Management and Respiratory Care After Cardiac Arrest Oxygenation, Ventilation, Infection, and Injury

Journal

CHEST
Volume 153, Issue 6, Pages 1466-1477

Publisher

ELSEVIER
DOI: 10.1016/j.chest.2017.11.012

Keywords

cardiac arrest; cardiopulmonary resuscitation; critical care; mechanical ventilation

Ask authors/readers for more resources

Return of spontaneous circulation after cardiac arrest results in a systemic inflammatory state called the post-cardiac arrest syndrome, which is characterized by oxidative stress, coagulopathy, neuronal injury, and organ dysfunction. Perturbations in oxygenation and ventilation may exacerbate secondary injury after cardiac arrest and have been shown to be associated with poor outcome. Further, patients who experience cardiac arrest are at risk for a number of other pulmonary complications. Up to 70% of patients experience early infection after cardiac arrest, and the respiratory tract is the most common source. Vigilance for early-onset pneumonia, as well as aggressive diagnosis and early antimicrobial agent administration are important components of critical care in this population. Patients who experience cardiac arrest are at risk for the development of ARDS. Risk factors include aspiration, pulmonary contusions (from chest compressions), systemic inflammation, and reperfusion injury. Early evidence suggests that they may benefit from ventilation with low tidal volumes. Meticulous attention to mechanical ventilation, early assessment and optimization of respiratory gas exchange, and therapies targeted at potential pulmonary complications may improve outcomes after cardiac arrest.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States

Mark W. Tenforde, Wesley H. Self, Yuwei Zhu, Eric A. Naioti, Manjusha Gaglani, Adit A. Ginde, Kelly Jensen, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Tresa McNeal, Shekhar Ghamande, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Heidi L. Erickson, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Arnold S. Monto, Akram Khan, Catherine L. Hough, Laurence W. Busse, Caitlin ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Hilary M. Babcock, Jennie H. Kwon, Matthew C. Exline, Mena M. Botros, Adam S. Lauring, Nathan Shapiro, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Todd W. Rice, Ian D. Jones, William B. Stubblefield, Adrienne Baughman, Kelsey N. Womack, Jillian P. Rhoads, Christopher J. Lindsell, Kimberly W. Hart, Caitlin Turbyfill, Samantha Olson, Nancy Murray, Katherine Adams, Manish M. Patel

Summary: Among hospitalized adults, the effectiveness of the two-dose mRNA vaccine against COVID-19-associated hospitalization decreased from 90% to 82% after 6 months post-vaccination. This study highlights the limited long-term durability of protection provided by the COVID-19 mRNA vaccines against hospitalization.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients

Jennie H. Kwon, Mark W. Tenforde, Manjusha Gaglani, H. Keipp Talbot, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David J. Douin, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Sean D. Caspers, Matthew C. Exline, Mena Botros, Michelle N. Gong, Alex Li, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Akram Khan, Catherine L. Hough, Laurence W. Busse, Abhijit Duggal, Jennifer G. Wilson, Cynthia Perez, Steven Y. Chang, Christopher Mallow, Randal Rovinski, Hilary M. Babcock, Adam S. Lauring, Laura Felley, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Todd W. Rice, Kelsey N. Womack, Christopher J. Lindsell, Kimberly W. Hart, Adrienne Baughman, Samantha M. Olson, Stephanie Schrag, Miwako Kobayashi, Jennifer R. Verani, Manish M. Patel, Wesley H. Self

Summary: The effectiveness of COVID-19 mRNA vaccines in preventing COVID-19 hospitalization is lower for solid organ transplant (SOT) recipients compared to immunocompetent individuals and those with other immunocompromising conditions. Among SOT recipients, receiving 3 doses of an mRNA vaccine provides significantly greater protection than receiving 2 doses.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Adam S. Lauring, Mark W. Tenforde, James D. Chappell, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David J. Douin, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Heidi L. Erickson, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Arnold S. Monto, Akram Khan, Catherine L. Hough, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Hilary M. Babcock, Jennie H. Kwon, Natasha Halasa, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Kelsey N. Womack, Jillian P. Rhoads, Christopher J. Lindsell, Kimberly W. Hart, Yuwei Zhu, Katherine Adams, Stephanie J. Schrag, Samantha M. Olson, Miwako Kobayashi, Jennifer R. Verani, Manish M. Patel, Wesley H. Self

Summary: mRNA vaccines were highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. Three vaccine doses were required for protection against omicron, while two doses provided protection against delta and alpha variants. Omicron variant showed lower disease severity compared to delta variant but still resulted in morbidity and mortality. Vaccinated patients had lower disease severity than unvaccinated patients for all the variants.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Immunology

Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States

Nathaniel M. Lewis, Wesley H. Self, Manjusha Gaglani, Adit A. Ginde, David J. Douin, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Shekhar A. Ghamande, Tresa A. McNeal, Nathan Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Heidi L. Erickson, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Arnold S. Monto, Akram Khan, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Hilary M. Babcock, Jennie H. Kwon, Matthew C. Exline, Adam S. Lauring, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Todd W. Rice, Jillian P. Rhoads, Ian D. Jones, William B. Stubblefield, Adrienne Baughman, Kelsey N. Womack, Christopher J. Lindsell, Kimberly W. Hart, Yuwei Zhu, Katherine Adams, Manish M. Patel, Mark W. Tenforde

Summary: The Ad26.COV2.S COVID-19 vaccine has shown a high effectiveness in reducing the risk of hospitalization among adults in the US and this effectiveness lasts for at least 6 months post-vaccination. Additionally, vaccinated immunocompetent patients who were hospitalized for COVID-19 were less likely to require invasive mechanical ventilation or die compared to unvaccinated patients.

CLINICAL INFECTIOUS DISEASES (2022)

Article Critical Care Medicine

Awareness With Paralysis Among Critically Ill Emergency Department Patients: A Prospective Cohort Study*

Brian M. Fuller, Ryan D. Pappal, Nicholas M. Mohr, Brian W. Roberts, Brett Faine, Julianne Yeary, Thomas Sewatsky, Nicholas J. Johnson, Brian E. Driver, Enyo Ablordeppey, Anne M. Drewry, Brian T. Wessman, Yan Yan, Marin H. Kollef, Christopher R. Carpenter, Michael S. Avidan

Summary: The objective of this study was to assess the proportion of emergency department (ED) patients experiencing awareness with paralysis (AWP) and investigate modifiable variables associated with its occurrence. Data from 388 mechanically ventilated adult patients that received neuromuscular blockers were analyzed. The study found that AWP was present in 3.4% of the patients, with the majority receiving rocuronium. Patients experiencing AWP had a higher perception of threat, placing them at greater risk for PTSD.

CRITICAL CARE MEDICINE (2022)

Review Clinical Neurology

Brain-Lung Crosstalk: Management of Concomitant Severe Acute Brain Injury and Acute Respiratory Distress Syndrome

Nassim Matin, Kasra Sarhadi, C. Patrick Crooks, Abhijit Lele, Vasisht Srinivasan, Nicholas J. Johnson, Chiara Robba, James A. Town, Sarah Wahlster

Summary: Management of SABI with ARDS involves various conflicts, such as the risk of elevated ICP with high PEEP, permissive hypercapnia with LPV, and conflicting data on corticosteroids in different SABI subtypes. Focus should be on individualized fluid management and oxygenation, along with careful monitoring and adjustments.

CURRENT TREATMENT OPTIONS IN NEUROLOGY (2022)

Article Critical Care Medicine

A pilot evaluation of respiratory mechanics during prehospital manual ventilation

Betty Y. Yang, Jennifer E. Blackwood, Jenny Shin, Sally Guan, Mengqi Gao, Dawn B. Jorgenson, James E. Boehl, Michael R. Sayre, Peter J. Kudenchuk, Thomas D. Rea, Heemun Kwok, Nicholas J. Johnson

Summary: This study investigated the respiratory mechanics of patients in the prehospital setting and found that tidal volumes were generally delivered within a safe range. Active CPR significantly affected respiratory mechanics, but bag size did not seem to have an impact.

RESUSCITATION (2022)

Article Medicine, General & Internal

Analysis of Epinephrine Dose, Targeted Temperature Management, and Neurologic and Survival Outcomes Among Adults With Out-of-Hospital Cardiac Arrest

Betty Y. Yang, Natalie Bulger, Richard Chocron, Catherine R. Counts, Chris Drucker, Lihua Yin, Megin Parayil, Nicholas J. Johnson, Nona Sotoodehenia, Peter J. Kudenchuk, Michael R. Sayre, Thomas D. Rea

Summary: The study observed an interaction between targeted temperature management (TTM) and epinephrine dose, indicating that the beneficial effects of TTM increased with higher doses of epinephrine, potentially attenuating the adverse effects associated with higher epinephrine doses.

JAMA NETWORK OPEN (2022)

Article Cardiac & Cardiovascular Systems

2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces

Myra H. Wyckoff, Robert Greif, Peter T. Morley, Kee-Chong Ng, Theresa M. Olasveengen, Eunice M. Singletary, Jasmeet Soar, Adam Cheng, Ian R. Drennan, Helen G. Liley, Barnaby R. Scholefield, Michael A. Smyth, Michelle Welsford, David A. Zideman, Jason Acworth, Richard Aickin, Lars W. Andersen, Diane Atkins, David C. Berry, Farhan Bhanji, Joost Bierens, Vere Borra, Bernd W. Bottiger, Richard N. Bradley, Janet E. Bray, Jan Breckwoldt, Clifton W. Callaway, Jestin N. Carlson, Pascal Cassan, Maaret Castren, Wei-Tien Chang, Nathan P. Charlton, Sung Phil Chung, Julie Considine, Daniela T. Costa-Nobre, Keith Couper, Thomaz Bittencourt Couto, Katie N. Dainty, Peter G. Davis, Maria Fernanda de Almeida, Allan R. de Caen, Charles D. Deakin, Therese Djarv, Michael W. Donnino, Matthew J. Douma, Jonathan P. Duff, Cody L. Dunne, Kathryn Eastwood, Walid El-Naggar, Jorge G. Fabres, Joe Fawke, Judith Finn, Elizabeth E. Foglia, Fredrik Folke, Elaine Gilfoyle, Craig A. Goolsby, Asger Granfeldt, Anne-Marie Guerguerian, Ruth Guinsburg, Karen G. Hirsch, Mathias J. Holmberg, Shigeharu Hosono, Ming-Ju Hsieh, Cindy H. Hsu, Takanari Ikeyama, Tetsuya Isayama, Nicholas J. Johnson, Vishal S. Kapadia, Mandira Daripa Kawakami, Han-Suk Kim, Monica Kleinman, David A. Kloeck, Peter J. Kudenchuk, Anthony T. Lagina, Kasper G. Lauridsen, Eric J. Lavonas, Henry C. Lee, Yiqun (Jeffrey) Lin, Andrew S. Lockey, Ian K. Maconochie, R. John Madar, Carolina Malta Hansen, Siobhan Masterson, Tasuku Matsuyama, Christopher J. D. McKinlay, Daniel Meyran, Patrick Morgan, Laurie J. Morrison, Vinay Nadkarni, Firdose L. Nakwa, Kevin J. Nation, Ziad Nehme, Michael Nemeth, Robert W. Neumar, Tonia Nicholson, Nikolaos Nikolaou, Chika Nishiyama, Tatsuya Norii, Gabrielle A. Nuthall, Brian J. O'Neill, Yong-Kwang Gene Ong, Aaron M. Orkin, Edison F. Paiva, Michael J. Parr, Catherine Patocka, Jeffrey L. Pellegrino, Gavin D. Perkins, Jeffrey M. Perlman, Yacov Rabi, Amelia G. Reis, Joshua C. Reynolds, Giuseppe Ristagno, Antonio Rodriguez-Nunez, Charles C. Roehr, Mario Rudiger, Tetsuya Sakamoto, Claudio Sandroni, Taylor L. Sawyer, Steve M. Schexnayder, Georg M. Schmolzer, Sebastian Schnaubelt, Federico Semeraro, Markus B. Skrifvars, Christopher M. Smith, Takahiro Sugiura, Janice A. Tijssen, Daniele Trevisanuto, Patrick Van de Voorde, Tzong-Luen Wang, Gary M. Weiner, Jonathan P. Wyllie, Chih-Wei Yang, Joyce Yeung, Jerry P. Nolan, Katherine M. Berg

Summary: This article summarizes the International Liaison Committee on Resuscitation's International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. It covers a wide range of topics related to resuscitation and provides consensus treatment recommendations based on evidence quality assessment. The article also highlights knowledge gaps for future research.

CIRCULATION (2022)

Article Critical Care Medicine

Factors Associated with Early Withdrawal of Life-Sustaining Treatments After Out-of-Hospital Cardiac Arrest: A Subanalysis of a Randomized Trial of Prehospital Therapeutic Hypothermia

Sarah Wahlster, Kyle Danielson, Lindy Craft, Nassim Matin, James A. Town, Vasisht Srinivasan, Glenn Schubert, David Carlbom, Francis Kim, Nicholas J. Johnson, David Tirschwell

Summary: This study found that nearly one quarter of deaths after out-of-hospital cardiac arrest were due to early WLST-N. Lack of neurological consultation and accurate multimodal prognostication led to underuse of guideline-concordant practices. The coadministration of sedating medications before early WLST-N may confound neurological examinations.

NEUROCRITICAL CARE (2023)

Article Critical Care Medicine

Scoping review of echocardiographic parameters associated with diagnosis and prognosis after resuscitated sudden cardiac arrest

Linda Liu, Aris Karatasakis, Peter J. Kudenchuk, James N. Kirkpatrick, Michael R. Sayre, David J. Carlbom, Nicholas J. Johnson, Jeffrey L. Probstfield, Catherine Counts, Kelley R. H. Branch

Summary: This study analyzed published data on early post-resuscitation echocardiography, and found limited evidence supporting its use in determining the cardiac causes of sudden death and predicting prognosis. Further research is needed to enhance the clinical application of early echocardiographic findings in post arrest care.

RESUSCITATION (2023)

Article Immunology

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022

Nathaniel M. Lewis, Nancy Murray, Katherine Adams, Diya Surie, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David J. Douin, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Harith Ali, Matthew E. Prekker, Anne E. Frosch, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Arnold S. Monto, Adam S. Lauring, Akram Khan, Catherine L. Hough, Laurence W. Busse, William Bender, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Hilary M. Babcock, Jennie H. Kwon, James D. Chappell, Natasha Halasa, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Christopher J. Lindsell, Kimberly W. Hart, Jillian P. Rhoads, Meredith L. McMorrow, Mark W. Tenforde, Wesley H. Self, Manish M. Patel

Summary: This study found that individuals who received a primary series plus a booster dose of COVID-19 vaccine had a lower risk of hospitalization compared to those who received a complete vaccine series. The relative vaccine effectiveness (rVE) showed a 66% reduction in COVID-19 hospitalization risk for boosted vaccine recipients compared to those with a primary series only, while the absolute vaccine effectiveness (aVE) showed an 81% reduction in hospitalization risk for the same group.

OPEN FORUM INFECTIOUS DISEASES (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Norepinephrine Versus Epinephrine For Post-Cardiac Arrest Shock In The Prehospital Setting: A Retrospective Analysis

Emma R. Wender, Ryan A. Cocca, Catherine Counts, Michael R. Sayre, Charles Maynard, Nicholas J. Johnson

CIRCULATION (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Lung Parenchymal And Pleural Findings On Computed Tomography After Out-of-Hospital Cardiac Arrest

Maranda Newton, Catherine Counts, Basar Sarikaya, Vasisht Srinivasan, Kelley R. Branch, Nicholas J. Johnson

CIRCULATION (2022)

No Data Available